The future of bioresorbable vascular scaffolds: niche or workhorse devices?
作者信息
Lahoud Rony, Ellis Stephen
机构信息
Department of Cardiology, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA.
出版信息
Coron Artery Dis. 2017 Sep;28(6):449-451. doi: 10.1097/MCA.0000000000000513.
PMID:28644214
Abstract
摘要
相似文献
1
The future of bioresorbable vascular scaffolds: niche or workhorse devices?
Coron Artery Dis. 2017 Sep;28(6):449-451. doi: 10.1097/MCA.0000000000000513.
2
Bioresorbable vascular scaffolds: the shape of things to come?
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):472-3. doi: 10.1002/ccd.24362. Epub 2012 Apr 27.
3
Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology.
Methodist Debakey Cardiovasc J. 2018 Jan-Mar;14(1):42-49. doi: 10.14797/mdcj-14-1-42.
4
Bioresorbable Stents: Is This Where We Are Headed?
Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):342-55. doi: 10.1016/j.pcad.2015.08.011. Epub 2015 Aug 28.
5
Polymeric bioresorbable coronary scaffolds: the hype is over, but the dream lives on.
EuroIntervention. 2018 Jan 20;13(13):1506-1509. doi: 10.4244/EIJV13I13A242.
6
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions.
JACC Cardiovasc Interv. 2017 Apr 10;10(7):743-745. doi: 10.1016/j.jcin.2017.01.038.
7
Bioresorbable vascular scaffolds: Time to absorb past lessons or fade away?
Arch Cardiovasc Dis. 2018 Apr;111(4):229-232. doi: 10.1016/j.acvd.2018.04.001. Epub 2018 Apr 17.
8
Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease.
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.116.003978.
9
Revascularization in 2017: Technical and diagnostic improvements in PCI: more pieces in the puzzle.
Nat Rev Cardiol. 2018 Feb;15(2):80-82. doi: 10.1038/nrcardio.2017.205. Epub 2017 Dec 14.
10
Why Bioresorbable Vascular Scaffold Should Be Approved for Marketing in the United States.
Cardiovasc Revasc Med. 2015 Oct-Nov;16(7):379-80. doi: 10.1016/j.carrev.2015.10.001.
Zotero 插件